Takeda acquires investigational coeliac therapy

22nd October 2019 Uncategorised 0

The Japanese pharma giant acquired the drug based on results from a phase IIa trial, in which the drug met its primary endpoint.

More: Takeda acquires investigational coeliac therapy
Source: News